Code | 5051D | ||||||||||
MA number | 83/0155/20-S | ||||||||||
Product Form: | tbl flm 84x5 mg (blis.PVC/PVDC/Al) | ||||||||||
MA Status: | R - Valid Marketing Authorisation | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | ARDEZ Pharma, spol. s r.o., Czechia | ||||||||||
Therapeutic Class: | 83 - VASODILATANTIA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Container: | blister PVC/PVDC/Al | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 13.07.2020 |
Validity: | 13.07.2025 |
MA renewed: | Renewal application submitted |
SPC: | SPC_Tadard 5 mg_tbl flm_03_2024.pdf |
PIL: | PIL_Tadard 5 mg_tbl flm_03_2024.pdf |
Safety feature | Yes |
Data update: | 14.07.2020 |